The team who lead the offering includes Oded Har-Even, Shy Baranov, Howard Berkenblit and Adi Osovsky. Maxim Group LLC acted as lead placement agent for the offering.
June, 2015
Attorneys Oded Har-Even and Howard Berkenbilt from our U.S. Capital Markets department, represented the company in it's acquisition by Francisco Partners L.P in an amount of $438 million.
May, 2015
A ZAG-S&W Team represented Cellect Biotechnology Ltd. in its initial public offering in the United States of 1,292,308 American Depository Shares (ADSs) and warrants to purchase up to 969,231 ADSs.
The gross proceeds to Cellect from this offering are $8.4 million.
July, 2016
Attorneys Oded Har Even, Howard Berkenblit and David Huberman represented RADCOM Ltd. In an underwritten public offering of approximately $23 million. ZAG-S&W handled the transaction in its entire legal and business aspects.
May, 2016
Aegis Capital Corp. is an investment bank and underwriter. Rennova Health's common stock and warrants are listed on the NASDAQ Capital Market.
December, 2015
Attorneys Oded Har-Even, Howard Berkenblit, Rob Condon and Ron Ben Bassat represented the company.
July, 2016
The ZAG-S&W team included Oded Har-Even, Howard Berkenblit, Rob Condon, Shy Baranov, David Huberman, Ron Ben-Bassat and Hila Nahum.
September, 2016
The Legal 500 United States recommended Sullivan & Worcester in 14 of its practice areas and noted 36 of its lawyers in the 2016 edition. June 15, 2016
The Legal 500 US Awards 2015 has recognized Sullivan & Worcester as the winner in the area of Real Estate - Real Estate Investment Trusts (REITs).
June 10, 2015
This Client Advisory discusses a new SEC rule under the Dodd-Frank Act requiring that public companies present the ratio of their chief executive officer’s total annual compensation to their median worker's compensation.
This Client Advisory discusses Regulation A+ and the creation of a new category of exempt private placements. (PDF)